Celiac Disease & Gluten-free Diet Information at Celiac.com - http://www.celiac.com
Journal of Gluten Sensitivity Article References - Past Issues
http://www.celiac.com/articles/21862/1/Journal-of-Gluten-Sensitivity-Article-References---Past-Issues/Page1.html
Scott Adams
In 1994 I was diagnosed with celiac disease, which led me to create Celiac.com in 1995. I created this site for a single purpose: To help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives. Celiac.com was the first site on the Internet dedicated solely to celiac disease, and since then it has become an invaluable resource to people worldwide who seek information about celiac disease and the gluten-free diet.

In 1998 I created The Gluten-Free Mall, Your Special Diet Superstore! which was also another Internet first—it was the first gluten-free food site to offer a shopping cart-style interface, and the ability for people to order gluten-free products manufactured by many different companies at a single Web site.

I am also co-author of the book Cereal Killers, and founder and publisher of Journal of Gluten Sensitivity.
 
By Scott Adams
Published on 10/16/2006
 
Journal of Gluten Sensitivity Article References - Past Issues
Journal of Gluten Sensitivity Article References

Journal of Gluten Sensitivity Article References - Past Issues

Autumn 2006 Issue

A Look at Essential Fatty Acids
By Roy S. Jamron

References:

  1. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006 Jul;118(1):e197-201.
  2. Heymans HS, van den Heuvel CG, Smit W, Steendijk R. Catch-up growth following long-term administration of essential fatty acids in a girl with growth failure and essential fatty acid deficiency. Acta Paediatr Scand. 1982 Nov;71(6):1037-9.
  3. Puri BK, Richardson AJ. Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Arch Gen Psychiatry. 1998 Feb;55(2):188-9.
  4. AM Hill, JD Buckley, KJ Murphy, DA Saint, AM Morris, PRC Howe. Combined effects of omega-3 supplementation and regular exercise on body composition and cardiovascular risk factors. Nutritional Physiology Research Centre, University of South Australia and University of Adelaide, SA 5005
  5. Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. 2003 Nov;126(1):1-27.
  6. Hirai H. Prostaglandin D2 in allergy: PGD2 has dual receptor systems. Nippon Yakurigaku Zasshi. 2004 Jan;123(1):15-22.
  7. Santos J, Bayarri C, Saperas E, Nogueiras C, Antolin M, Mourelle M, Cadahia A, Malagelada JR. Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy. Gut. 1999 Oct;45(4):553-8.
  8. Obata T, Nagakura T, Masaki T, Maekawa K, Yamashita K. Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy. 1999 Aug;29(8):1129-35.
  9. Boelsma E, Hendriks HF, Roza L. Nutritional skin care: health effects of micronutrients and fatty acids. Am J Clin Nutr. 2001 May;73(5):853-64.
  10. Gniadecka M, Faurskov Nielsen O, Christensen DH, Wulf HC. Structure of water, proteins, and lipids in intact human skin, hair, and nail. J Invest Dermatol. 1998 Apr;110(4):393-8.
  11. Ziboh VA. The significance of polyunsaturated fatty acids in cutaneous biology. Lipids. 1996 Mar;31 Suppl:S249-53.
  12. Wertz PW, Downing DT. Integral lipids of human hair. Lipids. 1988 Sep;23(9):878-81.
  13. Bjerve KS. n-3 fatty acid deficiency in man. J Intern Med Suppl. 1989;731:171-5.
  14. Bjerve KS, Thoresen L, Mostad IL, Alme K. Alpha-linolenic acid deficiency in man: effect of essential fatty acids on fatty acid composition. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:862-5.
  15. Harding CR, Moore AE, Rogers JS, Meldrum H, Scott AE, McGlone FP. Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch Dermatol Res. 2002 Jul;294(5):221-30.
  16. Logan AC, Lesperance F. Primary nocturnal enuresis: omega-3 fatty acids may be of therapeutic value. Med Hypotheses. 2005;64(6):1188-91.
  17. Kuznetsova AA, Shakhmatova EI, Prutskova NP, Natochin YV. Possible role of prostaglandins in pathogenesis of nocturnal enuresis in children. Scand J Urol Nephrol. 2000 Feb;34(1):27-31.
  18. Haylor J, Lote CJ. Renal function in conscious rats after indomethacin. Evidence for a tubular action of endogenous prostaglandins. J Physiol. 1980 Jan;298:371-81.
  19. Haylor J. Prostaglandin synthesis and renal function in man. J Physiol. 1980 Jan;298:383-96.
  20. Lin DS, Conner WE. Are the n-3 fatty acids from dietary fish oil deposited in the triglyceride stores of adipose tissue? Am J Clin Nutr. 1990 Apr;51(4):535-9.
  21. Krajcovicova-Kudlackova M, Klvanova J, Dusinska M. Polyunsaturated Fatty Acid Plasma Content in Groups of General Population with lowvitamin B6 or low iron serum levels. Ann Nutr Metab. 2004;48(2):118-21.
  22. Bergami R, Maranesi M, Marchetti M, Sangiorgi Z, Tolomelli B. Influence of dietary n-3 polyunsaturated fatty acids on plasma lipemic effect of vitamin B6 deficiency. Int J Vitam Nutr Res. 1999 Sep;69(5):315-21.
  23. Saareks V, Mucha I, Sievi E, Riutta A. Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man. Pharmacol Toxicol. 1999 Jun;84(6):274-80.
  24. Despret S, Dinh L, Clement M, Bourre JM. Alteration of delta-6 desaturase by vitamin E in rat brain and liver. Neurosci Lett. 1992 Sep 28;145(1):19-22.
  25. Gardiner NS, Duncan JR. Enhanced prostaglandin synthesis as a mechanism for inhibition of melanoma cell growth by ascorbic acid. Prostaglandins Leukot Essent Fatty Acids. 1988 Nov;34(2):119-26.
  26. Soma M, Cunnane SC, Horrobin DF, Manku MS, Honda M, Hatano M. Effects of low magnesium diet on the vascular prostaglandin and fatty acid metabolism in rats. Prostaglandins. 1988 Oct;36(4):431-41.
  27. Nigam S, Averdunk R, Gunther T. Alteration of prostanoid metabolism in rats with magnesium deficiency. Prostaglandins Leukot Med. 1986 Jul;23(1):1-10.
  28. Ayala S, Brenner RR. Essential fatty acid status in zinc deficiency. Effect on lipid and fatty acid composition, desaturation activity and structure of microsomal membranes of rat liver and testes. Acta Physiol Lat Am. 1983;33(3):193-204.
  29. Fidanza A, Audisio M. Vitamins and lipid metabolism. Acta Vitaminol Enzymol. 1982;4(1-2):105-14.
  30. Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, Green PH. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. Am J Med. 2006 Sep;119(9):786-90.
  31. Vuoristo M, Tilvis R, Miettinen TA. Serum plant sterols and lathosterol related to cholesterol absorption in coeliac disease. Clin Chim Acta. 1988 May 31;174(2):213-24.
  32. Branski D, Hurvitz H, Halevi A, Klar A, Navon P, Weidenfeld J. Eicosanoids content in small intestinal mucosa of children with celiac disease. J Pediatr Gastroenterol Nutr. 1992 Feb;14(2):173-6.
  33. Lavo B, Knutson L, Loof L, Hallgren R. Gliadin challenge-induced jejunal prostaglandin E2 secretion in celiac disease. Gastroenterology. 1990 Sep;99(3):703-7.
  34. Steel DM, Ryd W, Ascher H, Strandvik B. Abnormal Fatty Acid Pattern in Intestinal Mucosa of Children With Celiac Disease Is Not Reflected in Serum Phospholipids. J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):318-323.
  35. Gookin JL, Galanko JA, Blikslager AT, Argenzio RA. PG-mediated closure of paracellular pathway and not restitution is the primary determinant of barrier recovery in acutely injured porcine ileum. Am J Physiol Gastrointest Liver Physiol. 2003 Nov;285(5):G967-79. Epub 2003 Jun 11.
  36. Blikslager AT, Roberts MC, Rhoads JM, Argenzio RA. Prostaglandins I2 and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum. J Clin Invest. 1997 Oct 15;100(8):1928-33.
  37. Hirata K, Horie T. Stimulation of intestinal epithelial restitution by prostaglandin E(1) analogue. Cancer Chemother Pharmacol. 2003 Mar;51(3):216-20. Epub 2003 Feb 26.
  38. Gao F, Nakamaru M, Masubuchi Y, Horie T. Protective effect of a synthetic analog of prostaglandin E(1) on the small intestinal damage induced by the administration of methotrexate to rats. J Pharm Sci. 2001 Aug;90(8):1040-8.
  39. Hirata K, Horie T. A prostaglandin E1 analog, OP-1206, alleviates 5-fluorouracil-induced injury of rat small intestine. Res Commun Mol Pathol Pharmacol. 1999;104(3):243-51.
  40. Terzioglu T, Yalti T, Tezelman S. The effect of prostaglandin E1 on experimental colitis in the rat. Int J Colorectal Dis. 1997;12(2):63-6.
  41. Cali RL, Smyrk TC, Blatchford GJ, Thorson AG, Christensen MA. Effect of prostaglandin E1 and steroid on healing colonic anastomoses. Dis Colon Rectum. 1993 Dec;36(12):1148-51.
  42. Romano C, Cucchiara S, Barabino A, Annese V, Sferlazzas C. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol. 2005 Dec 7;11(45):7118-21.
  43. Nielsen AA, Jorgensen LG, Nielsen JN, Eivindson M, Gronbaek H, Vind I, Hougaard DM, Skogstrand K, Jensen S, Munkholm P, Brandslund I, Hey H. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. Aliment Pharmacol Ther. 2005 Dec;22(11-12):1121-8.
  44. Trebble TM, Wootton SA, May A, Erlewyn-Lajeunesse MD, Chakraborty A, Mullee MA, Stroud MA, Beattie RM. Essential fatty acid status in paediatric Crohn's disease: relationship with disease activity and nutritional status. Aliment Pharmacol Ther. 2003 Aug 15;18(4):433-42.
  45. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996 Jun 13;334(24):1557-60.
  46. Mowat AM. Prostaglandins and the induction of food sensitive enteropathy. Gut. 2000 Feb;46(2):154-5.
  47. Kainulainen H, Rantala I, Collin P, Ruuska T, Paivarinne H, Halttunen T, Lindfors K, Kaukinen K, Maki M. Blisters in the small intestinal mucosa of coeliac patients contain T cells positive for cyclooxygenase 2. Gut. 2002 Jan;50(1):84-9.
  48. Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut. 2005 Jan;54(1):54-9.
  49. Hazar B, Ergin M, Seyrek E, Erdogan S, Tuncer I, Hakverdi S. Cyclooxygenase-2 (Cox-2) expression in lymphomas. Leuk Lymphoma. 2004 Jul;45(7):1395-9.
  50. Yang P, Chan D, Felix E, Cartwright C, Menter DG, Madden T, Klein RD, Fischer SM, Newman RA. Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res. 2004 Jun;45(6):1030-9.
  51. Sravan Kumar G, Das UN. Cytotoxic action of alpha-linolenic and eicosapentaenoic acids on myeloma cells in vitro. Prostaglandins Leukot Essent Fatty Acids. 1997 Apr;56(4):285-93.
  52. Freeman HJ. Hepatobiliary and pancreatic disorders in celiac disease. World J Gastroenterol. 2006 Mar 14;12(10):1503-8.
  53. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology. 2006 May;130(6):1886-900.
  54. Liu XL, Fan DM. Protective effects of prostaglandin E1 on hepatocytes. World J Gastroenterol. 2000 Jun;6(3):326-329.
  55. Rudnick DA, Perlmutter DH, Muglia LJ. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8885-90.
  56. Solanki K, Matnani M, Kale M, Joshi K, Bavdekar A, Bhave S, Pandit A. Transcutaneous absorption of topically massaged oil in neonates. Indian Pediatr. 2005 Oct;42(10):998-1005.
  57. Skolnik P, Eaglstein WH, Ziboh VA. Human essential fatty acid deficiency: treatment by topical application of linoleic acid. Arch Dermatol. 1977 Jul;113(7):939-41.
  58. Friedman Z, Shochat SJ, Maisels MJ, Marks KH, Lamberth EL Jr. Correction of essential fatty acid deficiency in newborn infants by cutaneous application of sunflower-seed oil. Pediatrics. 1976 Nov;58(5):650-4.
  59. Bohles H, Bieber MA, Heird WC. Reversal of experimental essential fatty acid deficiency by cutaneous administration of safflower oil. Am J Clin Nutr. 1976 Apr;29(4):398-401.
  60. Sprecher H, Luthria DL, Mohammed BS, Baykousheva SP. Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J Lipid Res. 1995 Dec;36(12):2471-7.
  61. Qiu X, Hong H, MacKenzie SL. Identification of a Delta 4 fatty acid desaturase from Thraustochytrium sp. involved in the biosynthesis of docosahexanoic acid by heterologous expression in Saccharomyces cerevisiae and Brassica juncea. J Biol Chem. 2001 Aug 24;276(34):31561-6.
  62. Dorland's Medical Dictionary. Copyright 2004. WB Saunders. (See http://mercksource.com )
  63. Wallace JL, McKnight GW. Comparison of the damage-promoting effects of leukotrienes derived from eicosapentaenoic acid and arachidonic acid on the rat stomach. J Exp Med. 1990 May 1;171(5):1827-32.
  64. Bonnans C, Vachier I, Chavis C, Godard P, Bousquet J, Chanez P. Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med. 2002 Jun 1;165(11):1531-5.
  65. Serhan CN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):115-21.
  66. Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 2000 Aug;130(8):1925-31.
  67. Rubin D, Laposata M. Cellular interactions between n-6 and n-3 fatty acids: a mass analysis of fatty acid elongation/desaturation, distribution among complex lipids, and conversion to eicosanoids. J Lipid Res. 1992 Oct;33(10):1431-40.
  68. Maroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol. 2006 Apr;65(4):326-31.
  69. Bakhle YS. Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors. Drugs Today (Barc). 1999 Apr-May;35(4-5):237-50.
  70. Parente L, Perretti M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol. 2003 Jan 15;65(2):153-9.
  71. Sigthorsson G, Simpson RJ, Walley M, Anthony A, Foster R, Hotz-Behoftsitz C, Palizban A, Pombo J, Watts J, Morham SG, Bjarnason I. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology. 2002 Jun;122(7):1913-23.
  72. Slomma N, Becker K, Eder K. The effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acids on delta4-desaturation in HepG2 cells. Int J Vitam Nutr Res. 2004 Jul;74(4):243-6.
  73. Koletzko B. Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Paediatr. 1992 Apr;81(4):302-6.
  74. Mahfouz MM, Smith TL, Kummerow FA. Effect of dietary fats on desaturase activities and the biosynthesis of fatty acids in rat-liver microsomes. Lipids. 1984 Mar;19(3):214-22.
  75. Mahfouz M. Effect of dietary trans fatty acids on the delta 5, delta 6 and delta 9 desaturases of rat liver microsomes in vivo. Acta Biol Med Ger. 1981;40(12):1699-1705.
  76. Williams CM, Burdge G. Long-chain n-3 PUFA: plant v. marine sources. Proc Nutr Soc. 2006 Feb;65(1):42-50.
  77. Horrobin DF. Fatty acid metabolism in health and disease: the role of delta-6-desaturase. Am J Clin Nutr. 1993 May;57(5 Suppl):732S-736S; discussion 736S-737S.
  78. Biagi PL, Bordoni A, Hrelia S, Celadon M, Horrobin DF. Gamma-linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome delta 6-desaturase activity. Biochim Biophys Acta. 1991 May 8;1083(2):187-92.

Winter 2006 Issue

Unraveling Fibromyalgia
By Roy S. Jamron

Links:
FM Monograph - Fibromyalgia: Symptoms, Diagnosis, Treatment & Research. (See "Learn about Fibromyalgia" - Overview)
http://www.fmpartnership.org
The Scientific Basis for Understanding Pain in Fibromyalgia - Robert Bennett, MD, FRCP
http://www.myalgia.com/Scientific%20basis.htm
Your Liver Functions
http://janis7hepc.com/Your%20Liver%20Functions.htm
The Liver Detoxification Pathways
http://www.liverdoctor.com/03_detoxpathways.asp
Toxicology - an introduction to occupational and environmental toxicology
http://www.agius.com/hew/resource/toxicol.htm
Xenoestrogens and Breast Cancer: Nowhere to Run
http://www.fwhc.org/health/xeno.htm
Olestra seen as antidote to toxins
http://www.cincypost.com/2005/01/04/oles010405.html
Yo-yo Diet Redistributes Hexachlorobenzene in Body Tissue
http://www.the-aps.org/press/journal/04/36.htm
Adipose tissue at entheses: the rheumatological implications of its distribution. A potential site of pain and stress dissipation?
http://ard.bmjjournals.com/cgi/content/full/63/12/1549

References:

  1. Frissora CL, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep. 2005 Aug;7(4):264-71.
  2. Wallace DJ, Hallegua DS. Fibromyalgia: the gastrointestinal link. Curr Pain Headache Rep. 2004 Oct;8(5):364-8.
  3. Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E. Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci. 2003 Apr;48(4):761-4.
  4. FM Monograph - Fibromyalgia: symptoms, diagnosis, treatment & research. National Fibromyalgia Partnership, Inc. 2004.
  5. Bennet RM. Chronic widespread pain and the fibromyalgia construct. Oregon Health Sciences University, Portland, Oregon.
  6. Neumann L, Buskila D. Epidemiology of fibromyalgia. Curr Pain Headache Rep. 2003 Oct;7(5):362-8.
  7. Simms RW. Fibromyalgia is not a muscle disorder. Am J Med Sci. 1998 Jun;315(6):346-50.
  8. Simms RW. Is there muscle pathology in fibromyalgia syndrome? Rheum Dis Clin North Am. 1996 May;22(2):245-66.
  9. Blanco LE, de Serres FJ, Fernandez-Bustillo E, Kassam DA, Arbesu D, Rodriguez C, Torre JC. Alpha1-antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia. Med Hypotheses. 2005;64(4):759-69.
  10. Blanco I, Canto H, de Serres FJ, Fernandez-Bustillo E, Rodriguez MC. Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency. J Rheumatol. 2004 Oct;31(10):2082-5.
  11. Aldonyte R, Jansson L, Janciauskiene S. Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro. BMC Cell Biol. 2004 Mar 29;5:11.
  12. Bristow CL, Patel H, Arnold RR. Self antigen prognostic for human immunodeficiency virus disease progression. Clin Diagn Lab Immunol. 2001 Sep;8(5):937-42.
  13. Shapiro L, Pott GB, Ralston AH. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J. 2001 Jan;15(1):115-122.
  14. Simms RW, Zerbini CA, Ferrante N, Anthony J, Felson DT, Craven DE. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. The Boston City Hospital Clinical AIDS Team. Am J Med. 1992 Apr;92(4):368-74.
  15. Buskila D, Gladman DD, Langevitz P, Urowitz S, Smythe HA. Fibromyalgia in human immunodeficiency virus infection. J Rheumatol. 1990 Sep;17(9):1202-6.
  16. Wagnerova M, Wagner V, Kriz J, Wokounova D, Madlo Z, Slesingerova B. The morbidity of children with decreased serum levels of alpha 1-antitrypsin in an air pollution area. Czech Med. 1980;3(4):280-8.
  17. Davison S. Coeliac disease and liver dysfunction. Arch Dis Child. 2002 Oct;87(4):293-6.
  18. Duggan JM, Duggan AE. Systematic review: the liver in coeliac disease. Aliment Pharmacol Ther. 2005 Mar 1;21(5):515-8.
  19. Abdo A, Meddings J, Swain M. Liver abnormalities in celiac disease. Clin Gastroenterol Hepatol. 2004 Feb;2(2):107-12.
  20. Bennett RM. Adult growth hormone deficiency in patients with fibromyalgia. Curr Rheumatol Rep. 2002 Aug;4(4):306-12.
  21. Van Konynenburg RA. Is Glutathione depletion an important part of the pathogenesis of Chronic Fatigue Syndrome. Paper presented at the AACFS Seventh International Conference, Madison, Wisconsin, October 8-10, 2004
  22. Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WH. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):750-5.
  23. Sategna-Guidetti C, Volta U, Ciacci C, Usai P, Carlino A, De Franceschi L, Camera A, Pelli A, Brossa C. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol. 2001 Mar;96(3):751-7.
  24. Neeck G, Riedel W. Thyroid function in patients with fibromyalgia syndrome. J Rheumatol. 1992 Jul;19(7):1120-2.
  25. Lowe JC, Reichman AJ, Honeyman GS, Yellin J. Thyroid status of fibromyalgia patients. Clinical Bulletin of Myofascial Therapy, 3(1):47-53, 1998.
  26. Lowe JC, Honeyman-Lowe GS. Thyroid disease and fibromyalgia syndrome. Lyon Méditerranée Médical: Médecine du Sud-Est., 36(1):15-17, 2000.
  27. Malik R, Hodgson H. The relationship between the thyroid gland and the liver. QJM. 2002 Sep;95(9):559-69.
  28. Kelly GS. Peripheral metabolism of thyroid hormones: a review. Altern Med Rev. 2000 Aug;5(4):306-33.
  29. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004 Mar;134(3):489-92.
  30. Kidd PM. Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1997;1:155-176.
  31. Benjamin M, Redman S, Milz S, Buttner A, Amin A, Moriggl B, Brenner E, Emery P, McGonagle D, Bydder G. Adipose tissue at entheses: the rheumatological implications of its distribution. A potential site of pain and stress dissipation? Ann Rheum Dis. 2004 Dec;63(12):1549-55.
  32. Rajala MW, Scherer PE. Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003 Sep;144(9):3765-73.
  33. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004 Sep;92(3):347-55.
  34. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005 May;115(5):911-9
  35. Riordan SM, McIver CJ, Thomas DH, Duncombe VM, Bolin TD, Thomas MC. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol. 1997 Jun;32(6):556-63.
  36. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab. 2004 Apr;89(4):1869-78.
  37. Dieudonne MN, Leneveu MC, Giudicelli Y, Pecquery R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol. 2004 Mar;286(3):C655-61.
  38. Cassidy A, Milligan S. How significant are environmental estrogens to women? Climacteric. 1998 Sep;1(3):229-42.
  39. Starek A. Estrogens and organochlorine xenoestrogens and breast cancer risk. Int J Occup Med Environ Health. 2003;16(2):113-24.
  40. Daston GP, Gooch JW, Breslin WJ, Shuey DL, Nikiforov AI, Fico TA, Gorsuch JW. Environmental estrogens and reproductive health: a discussion of the human and environmental data. Reprod Toxicol. 1997 Jul-Aug;11(4):465-81.
  41. Waxman J, Zatzkis SM. Fibromyalgia and menopause. Examination of the relationship. Postgrad Med. 1986 Sep 15;80(4):165-7, 170-1.
  42. Sverdrup B. Use less cosmetics--suffer less from fibromyalgia? J Womens Health (Larchmt). 2004 Mar;13(2):187-94.
  43. Moser GA, McLachlan MS. A non-absorbable dietary fat substitute enhances elimination of persistent lipophilic contaminants in humans. Chemosphere. 1999 Oct;39(9):1513-21.
  44. Geusau A, Tschachler E, Meixner M, Sandermann S, Papke O, Wolf C, Valic E, Stingl G, McLachlan M. Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Lancet. 1999 Oct 54(9186):1266-7.
  45. Geusau A, Abraham K, Geissler K, Sator MO, Stingl G, Tschachler E. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects. Environ Health Perspect. 2001 Aug;109(8):865-9.
  46. Redgrave TG, Wallace P, Jandacek RJ, Tso P. Treatment with a dietary fat substitute decreased Arochlor 1254 contamination in an obese diabetic male. J Nutr Biochem. 2005 Jun;16(6):383-4.
  47. Jandacek RJ, Anderson N, Liu M, Zheng S, Yang Q, Tso P. Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene. Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G292-9.
  48. McLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K, Lyden AK, Gracely RH, Crofford LJ, Geisser ME, Sen A, Biswas P, Clauw DJ. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum. 2005 Nov;52(11):3660-9.
  49. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005 Apr;98(4):1154-62.
  50. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev. 2000 Jul;80(3):1055-81.
  51. Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E433-7.
  52. Steensberg A, Toft AD, Schjerling P, Halkjaer-Kristensen J, Pedersen BK. Plasma interleukin-6 during strenuous exercise: role of epinephrine. Am J Physiol Cell Physiol. 2001 Sep;281(3):C1001-4.
  53. Keller P, Keller C, Robinson LE, Pedersen BK. Epinephrine infusion increases adipose interleukin-6 gene expression and systemic levels in humans. J Appl Physiol. 2004 Oct;97(4):1309-12.
  54. Johnston DE. Special considerations in interpreting liver function tests. Am Fam Physician. 1999 Apr 15;59(8):2223-30.

Summer 2004 Issue

Additional Food Allergies = Incomplete Recovery or Refractory Sprue?
By Ron Hoggan

  1. Pizzuti D, Bortolami M, Mazzon E, Buda A, Guariso G, D’Odorico A, Chiarelli S, D’Inca R, De Lazzari F, Martines D. Transcriptional downregulation of tight junction protein ZO-1 in active coeliac disease is reversed after a gluten-free diet. Dig Liver Dis. 2004 May;36(5):337-41.
  2. Baker AL, et al. Refractory sprue: recovery after removal of non-gluten dietary proteins. Ann Intern Med. 1978 Oct;89(4):505-8.
  3. Volta U, et al. Antibodies to dietary antigens in coeliac disease. Scand J Gastroenterol. 1986 Oct;21(8):935-40.
  4. Mandal A, Mayberry J. Elemental diet in the treatment of refractory coeliac disease. Eur J Gastroenterol Hepatol. 2001 Jan;13(1):79-80.
  5. Kemeny DM, Urbanek R, Amlot PL, Ciclitira PJ, Richards D, Lessof MH.Sub-class of IgG in allergic disease. I. IgG sub-class antibodies in immediate and non-immediate food allergy. Clin Allergy. 1986 Nov;16(6):571-81.
  6. Paranos S, et al. Lack of cross-reactivity between casein and gliadin in sera from coeliac disease patients. Int Arch Allergy Immunol. 1998 Oct;117(2):152-4.
  7. Scott H, et al. Immune response patterns in coeliac disease. Serum antibodies to dietary antigens measured by an enzyme linked immunosorbent assay (ELISA). Clin Exp Immunol. 1984 Jul;57(1):25-32.

Immunoglobulin Deficiency and Celiac Disease
By Vijay Kumar, Ph.D., FACB

  1. Guandalini S, Gupta P. Celiac disease - a diagnostic challenge. Clin Appl Immun Rev 2002; 2:293-305.
  2. Guandalini S, Gupta P. Celiac disease - a diagnostic challenge. Clin Appl Immun Rev 2002; 2:293-305; Fasano A, et al. Prevalence of celiac disease in at risk and not-at-risk groups in the United States 2223; 163:286-292.
  3. Wolber R, et al. Lymphocytic gastritis in patients with celiac sprue or sprue like intestinal disease. Gastroenterology 1990; 98:310-315.
  4. Catassi, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287:1413-1419.
  5. Arranz E, Ferguson A. Intestinal antibody pattern of celiac disease: Occurrence in patients with normal jejunal biopsy histology. Gastroenterology 1993; 104:1263-72.
  6. Hill ID, et al. Celiac disease: Working group report of the first world congress of pediatric gastroenterology, hepatology, and nutrition. J. Pediatr Gastroenterol Nutr 2002; 35:S78-S88.
  7. Rosario et al. J Pediatr Gastroenterol Nutr 1998; 27:191-195.
  8. Vitoria JC, et al. Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr 1999; 29:571-4.
  9. Rittmeyer C, Rhoads JM. IgA deficiency causes false-negative endomysial antibody results in celiac disease. J Pediatr Gastroenterol Nutr. 1996; 23:504-6.
  10. Kumar V et al. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis. Clin Immunol. 2001; 98:378-82; Lagerqvist, C et al. Screening for adult coeliac disease - which serological marker(s) to use? Journal Intern Med. 2001; 250:241-248.
  11. Lilic D, Sewell WA. IgA deficiency: what we should-or should not-be doing. J Clint Pathol 2001; 54:337-8; Seidman EG, Hollander GA. Autoimmunity with immunodeficiency: a logical paradox. J Pediatr Gastroenterol Nutr. 1999; 28377-9.
  12. Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res. 1996;10:57-61.
  13. J. Paed. Gastroenterol. 1999:28:81-83.

Spring 2004 Issue

The Anemia and Celiac Disease Connection
By Cynthia Kupper, RD, CD

  1. Anemia, Vital and Health Statistics, Series 10, No. 200 , 1996. <http://www.cdc.gov/nchs/fastats/anemia.htm> Accessed 9/10/03
  2. Fasano A, Berti I, et al. Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States Arch Intern Med. 2003;163:286-292.
  3. Guandalini S. Celiac disease. School Nurse News. 2003 Mar;20(2):24-7.
  4. Sood A, Midha V, et al. Adult celiac disease in northern India. Indian J Gastroenterol. 2003 Jul-Aug;22(4):124-6.
  5. Sachdev A, Srinivasan V, et al. Adult onset celiac disease in north India. Trop Gastroenterol. 2002 Jul-Sep;23(3):117-9.
  6. Dobru D, Pascu O, et al. The prevalence of coeliac disease at endoscopy units in Romania: routine biopsies during gastroscopy are mandatory (a multicentre study). Rom J Gastroenterol. 2003 Jun;12(2):97-100.
  7. Zipser RD, Patel S, et al. Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci. 2003 Apr;48(4):761-4.
  8. Cranney A, Zarkadas M, et al. The Canadian celiac health survey – the Ottawa chapter pilot. BMC Gastroenterol. 2003; 3 (1): 8.
  9. Ransford RA, Hayes M, et al. A controlled, prospective screening study of celiac disease presenting as iron deficiency anemia. J Clin Gastroenterol. 2002 Sep;35(3):228-33.
  10. Howard MR, Turnbull AJ, et al. A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J Clin Pathol. 2002 Oct;55(10):754-7.
  11. Brooklyn TN, Di Mambro AJ, et al. Patients over 45 years with iron deficiency require investigation. Eur J Gastroenterol Hepatol. 2003 May;15(5):535-8.
  12. Sanders DS, Patel D, et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol. 2003 Apr;15(4):407-13.
  13. Dahele A, Ghosh S. Vitamin B12 deficiency in untreated celiac disease. Am J Gastroenterol. 2001 Mar;96(3):745-50.
  14. Dickey W. Low serum vitamin B12 is common in coeliac disease and is not due to autoimmune gastritis. Eur J Gastroenterol Hepatol. 2002 Apr;14(4):425-7.
  15. Iron-deficiency anemia in women. Harvard Women’s Health Watch, Nov 2002, Vol. 10 Issue 3, p3.
  16. Anemia Patient Education Sheets. Mayo Clinic website. www.mayoclinic.org. Accessed 9-5-03.
  17. Annibale B, Severi C, et al. Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol. 2001 Jan;96(1):132-7.

Are Commensal Bacteria with a Taste for Gluten the Missing Link in the Pathogenesis of Celiac Disease?
By Roy S. Jamron

  1. Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, Paparo F, Gasperi V, Limongelli MG, Cotichini R, D'Agate C, Tinto N, Sacchetti L, Tosi R, Stazi MA. The first large population based twin study of coeliac disease. Gut 2002 May;50(5):624-8.
  2. Bardella MT, Fredella C, Prampolini L, Marino R, Conte D, Giunta AM. Gluten sensitivity in monozygous twins: a long-term follow-up of five pairs. Am J Gastroenterol 2000 Jun;95(6):1503-5.
  3. Bingley PJ, Williams AJ, Norcross AJ, Unsworth DJ, Lock RJ, Ness AR, Jones RW. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 2004 Feb 7;328(735):322-3.
  4. Sollid LM. Breast milk against coeliac disease. Gut 2002 Dec;51(6):767-8.
  5. Nash S. Does exclusive breast-feeding reduce the risk of coeliac disease in children? Br J Community Nurs 2003 Mar;8(3):127-32.
  6. Ivarsson A, Hernell O, Stenlund H, Persson LA. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002 May;75(5):914-21.
  7. Peters U, Schneeweiss S, Trautwein EA, Erbersdobler HF. A case-control study of the effect of infant feeding on celiac disease. Ann Nutr Metab 2001;45(4):135-42.
  8. Stepankova R, Kofronova O, Tuckova L, Kozakova H, Cebra JJ, Tlaskalova-Hogenova H. Experimentally induced gluten enteropathy and protective effect of epidermal growth factor in artificially fed neonatal rats. J Pediatr Gastroenterol Nutr 2003 Jan;36(1):96-104.
  9. Martin R, Langa S, Reviriego C, Jiminez E, Marin ML, Xaus J, Fernandez L, Rodriguez JM. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003 Dec;143(6):754-8.
  10. Goldman AS. Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective. J Nutr 2000 Feb;130(2S Suppl):426S-431S.
  11. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003 Sep;91(441):48-55.
  12. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F, Collins JK. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 2001 Feb;73(2 Suppl):386S-392S.
  13. Mai V, Morris JG Jr. Colonic bacterial flora: changing understandings in the molecular age. J Nutr 2004 Feb;134(2):459-64
  14. Gronlund MM, Arvilommi H, Kero P, Lehtonen OP, Isolauri E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal Ed 2000 Nov;83(3):F186-92.
  15. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001 Feb 2;291(5505):881-4.
  16. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A 1999 Aug 17;96(17):9833-8.
  17. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002 Nov 26;99(24):15451-5.
  18. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003 Mar;4(3):269-73.
  19. Lanning D, Sethupathi P, Rhee KJ, Zhai SK, Knight KL. Intestinal microflora and diversification of the rabbit antibody repertoire. J Immunol 2000 Aug 15;165(4):2012-9.
  20. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol 2004 Jan 15;172(2):1118-24.
  21. Garcia-Lafuente A, Antolin M, Guarner F, Crespo E, Malagelada JR. Modulation of colonic barrier function by the composition of the commensal flora in the rat. Gut 2001 Apr;48(4):503-7.
  22. Bai AP, Ouyang Q, Zhang W, Wang CH, Li SF. Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. World J Gastroenterol 2004 Feb 1;10(3):455-7.
  23. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003 Feb 8;361(9356):512-9.
  24. Hill MJ. Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev 1997 Mar;6 Suppl 1:S43-5.
  25. Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of Crohn's disease. Gut 2004 Feb;53(2):246-50.
  26. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002 Sep;2(9):647-55.
  27. Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of coeliac disease. Int J Biochem Cell Biol 2004 Jan;36(1):17-24.
  28. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002 Jan 17;346(3):180-8.
  29. Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, Ullrich R. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 1999 Jan;44(1):17-25.
  30. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003 Feb;61(2):105-17.
  31. DeMeyer ES, Baar J. Dendritic Cells: The Sentry Cells of the Immune System. Oncology Education Services, Inc. http://oes.digiton.com/dcell/
  32. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002;20:621-67.
  33. Klein J, Sato A. The HLA system. First of two parts. N Engl J Med 2000 Sep 7;343(10):702-9.
  34. Stagg AJ, Hart AL, Knight SC, Kamm MA. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 2003 Oct;52(10):1522-9.
  35. Sundquist M, Rydstrom A, Wick MJ. Immunity to Salmonella from a dendritic point of view. Cell Microbiol 2004 Jan;6(1):1-11.
  36. Suhonen J, Komi J, Soukka J, Lassila O, Viljanen MK. Interaction between Borrelia burgdorferi and immature human dendritic cells. Scand J Immunol 2003 Jul;58(1):67-75.
  37. Uhlig HH, Powrie F. Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. J Clin Invest 2003 Sep;112(5):648-51.
  38. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001 Apr;2(4):361-7.
  39. Singh BP, Chauhan RS, Singhal LK. Toll-like receptors and their role in innate immunity. Current Science 2003 Oct;85(8):1156-1164.
  40. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003 Apr;3(4):331-41.
  41. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C. Structural basis for gluten intolerance in celiac sprue. Science 2002 Sep 27;297(5590):2275-9.
  42. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000 Mar;6(3):337-42.
  43. Todar K. Todar's Online Textbook of Bacteriology. Univ of Wisconsin Department of Bacteriology. http://www.textbookofbacteriology.net
  44. Monnet V. Bacterial oligopeptide-binding proteins. Cell Mol Life Sci 2003 Oct;60(10):2100-14.
  45. Foucaud C, Hemme D, Desmazeaud M. Peptide utilization by Lactococcus lactis and Leuconostoc mesenteroides. Lett Appl Microbiol 2001 Jan;32(1):20-5.
  46. Detmers FJ, Kunji ER, Lanfermeijer FC, Poolman B, Konings WN. Kinetics and specificity of peptide uptake by the oligopeptide transport system of Lactococcus lactis. Biochemistry 1998 Nov 24;37(47):16671-9.
  47. Vader W, Kooy Y, Van Veelen P, De Ru A, Harris D, Benckhuijsen W, Pena S, Mearin L, Drijfhout JW, Koning F. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002 Jun;122(7):1729-37.
  48. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J 1999 Oct;13(13):1787-95.
  49. Nardacci R, Lo Iacono O, Ciccosanti F, Falasca L, Addesso M, Amendola A, Antonucci G, Craxi A, Fimia GM, Iadevaia V, Melino G, Ruco L, Tocci G, Ippolito G, Piacentini M. Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol 2003 Apr;162(4):1293-303.
  50. Bowness JM, Tarr AH. Increase in transglutaminase and its extracellular products in response to an inflammatory stimulus by lipopolysaccharide. Mol Cell Biochem 1997 Apr;169(1-2):157-63.

Winter 2004 Issue

The Problem with Oats in the Gluten Sensitive Diet
By Ron Hoggan

  1. Storsrud S, Olsson M, Arvidsson Lenner R, Nilsson LA, Nilsson O, Kilander A. Adult coeliac patients do tolerate large amounts of oats. Eur J Clin Nutr. 2003 Jan;57(1):163-9.
  2. Kilmartin C, Lynch S, Abuzakouk M, Wieser H, Feighery C. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut. 2003 Jan;52(1):47-52.
  3. Janatuinen EK, Kemppainen TA, Julkunen RJ, Kosma VM, Maki M, Heikkinen M, Uusitupa MI. No harm from five year ingestion of oats in coeliac disease. Gut. 2002 Mar;50(3):332-5.
  4. Teschemacher H. Opioid receptor ligands derived from food proteins. Curr Pharm Des. 2003;9(16):1331-44. Review.
  5. Yoshikawa M, Takahashi M, Yang S. Delta opioid peptides derived from plant proteins. Curr Pharm Des. 2003;9(16):1325-30. Review.
  6. Horvath K, Graf L, Walcz E, Bodanszky H, Schuler D. Naloxone antagonises effect of alpha-gliadin on leucocyte migration in patients with coeliac disease. Lancet. 1985 Jul 27;2(8448):184-5.
  7. Zioudrou C, Streaty RA, Klee WA. Opioid peptides derived from food proteins. The exorphins. J Biol Chem. 1979 Apr 10;254(7):2446-9.
  8. Hoggan R. Considering wheat, rye, and barley proteins as aids to carcinogens. Med Hypotheses. 1997 Sep;49(3):285-8.
  9. Fukudome S, Yoshikawa M. Opioid peptides derived from wheat gluten: their isolation and characterization. FEBS Lett. 1992 Jan 13;296(1):107-11.
  10. Kuitunen P, Savilahti E, Verkasalo M. Late mucosal relapse in a boy with coeliac disease and cow’s milk allergy. Acta Paediatr Scand. 1986 Mar;75(2):340-2.
  11. Holmes, et. al. “Malignancy in coeliac disease - effect of a gluten free diet” Gut 1989; 30: 333-338
  12. Holmes GK. Coeliac disease and malignancy.Dig Liver Dis. 2002 Mar;34(3):229-37
  13. Collin P, Pukkala E, Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut. 1996 Apr;38(4):528-30.
  14. Chartrand LJ, Russo PA, Duhaime AG, Seidman EG. Wheat starch intolerance in patients with celiac disease. J Am Diet Assoc. 1997 Jun;97(6):612-8.

When Gluten Gets On Your Nerves
By Laura Yick

1. Hadjivassiliou M et al 2003. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 126: 685-91.
2. Tengah D et al 2002. Neurological complications of coeliac disease. Postgrad Med J 78: 393-98.
3. Hadjivassiliou, et al. 2002. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 72: 560-3
4. Volta U, et al. 2002. Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol 37: 1276-81.
5. Tursi A et al 2001. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol 96: 1507-1510.
6. Hadjivassiliou M, et al. 2003. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry 74: 1221-24.
7. Will AJ. 2000. The neurology and neuropathy of coeliac disease. Neuropathy and Applied Neurobio 226: 493-96.
8. Cross A, and Golumbek, P. 2003. Neurologic manifestations of celiac disease. Neurology 60: 1566-1568.
9. Hadjivassiliou M, et al. 2002. The humoral response in the pathogenesis of gluten ataxia. Neurology 58: 1221-26.

Winter 2003 Issue

Eating to Learn: How Grains Impact on Our Ability to Focus, Comprehend, Remember, Predict, and Survive
By Ron Hoggan

References:

  1. Kozlowska, Z: (1991). Results of investigation on children with coeliakia treated many years with glutethen free diet Psychiatria Polska. 25(2),130-134.
  2. Paul, K., Todt, J., Eysold, R. (1985) [EEG Research Findings in Children with Celiac Disease According to Dietary Variations]. Zeitschrift der Klinische Medizin. 40, 707-709.
  3. Grech, P.L., Richards, J., McLaren, S., Winkelman, J.H. (2000) Psychological sequelae and quality of life in celiac disease. Journal of Pediatric Gastroenterology and Nutrition 31(3): S4
  4. Reichelt, K., Sagedal, E., Landmark, J., Sangvic, B., Eggen, O., Helge, S. (1990a). The Effect of Gluten-Free Diet on Urinary peptide Excretion and Clinical State in Schizophrenia. Journal of Orthomolecular Medicine. 5(4), 169-181.
  5. Reichelt, K., Ekrem, J., Scott, H. (1990b). Gluten, Milk Proteins and Autism: DIETARY INTERVENTION EFFECTS ON BEHAVIOR AND PEPTIDE SECRETION. Journal of Applied Nutrition. 42(1), 1-11.
  6. Reichelt, K., Knivsberg, A., Lind, G., Nodland, M. (1991). Probable etiology and Possible Treatment of Childhood Autism. Brain Dysfunction. 4, 308-319.
  7. Hoggan, R. (1997a). Absolutism's Hidden Message for Medical Scientism. Interchange. 28(2/3), 183-189.
  8. Caterson ID, Gill TP. Obesity: epidemiology and possible prevention. Best Pract Res Clin Endocrinol Metab. 2002 Dec;16(4):595-610.
  9. Hennessy AR, Walker JD.Silent hypoglycaemia at the diabetic clinic. Diabet Med. 2002 Mar;19(3):261.
  10. Kue Young T, Chateau D, Zhang M. Factor analysis of ethnic variation in the multiple metabolic (insulin resistance) syndrome in three Canadian populations.Am J Human Biol. 2002 Sep-Oct;14(5):649-58.
  11. Wahab PJ, Meijer JW, Dumitra D, Goerres MS, Mulder CJ. Coeliac disease: more than villous atrophy.Rom J Gastroenterol. 2002 Jun;11(2):121-7.
  12. Catassi C, Ratsch IM, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, Frijia M, Bearzi I, Vizzoni L. Why is coeliac disease endemic in the people of the Sahara?Lancet. 1999 Aug 21;354(9179):647-8.
  13. Langleben DD, Acton PD, Austin G, Elman I, Krikorian G, Monterosso JR, Portnoy O, Ridlehuber HW, Strauss HW. Effects of Methylphenidate Discontinuation on Cerebral Blood Flow in Prepubescent Boys with Attention Deficit Hyperactivity Disorder.J Nucl Med. 2002 Dec;43(12):1624-1629.
  14. 2: Kim BN, Lee JS, Shin MS, Cho SC, Lee DS. Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder Statistical parametric mapping analysis. Eur Arch Psychiatry Clin Neurosci. 2002 Oct;252(5):219-25.
  15. Lou, H., Henriksen, L., Bruhn, P. (1984). Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Archives of Neurology. 825-829.
  16. De Santis A, Addolorato G, Romito A, Caputo S, Giordano A, Gambassi G, Taranto C, Manna R, Gasbarrini G. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J Intern Med. 1997 Nov;242(5):421-3.
  17. Knivsberg AM. Urine patterns, peptide levels and IgA/IgG antibodies to food proteins in children with dyslexia.Pediatr Rehabil. 1997 Jan-Mar;1(1):25-33.
  18. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 43-1988. A 52-year-old man with persistent watery diarrhea and aphasia.N Engl J Med. 1988 Oct 27;319(17):1139-48.
  19. Hadjivassiliou M, Boscolo S, Davies-Jones GA, Grunewald RA, Not T, Sanders DS, Simpson JE, Tongiorgi E, Williamson CA, Woodroofe NM. The humoral response in the pathogenesis of gluten ataxia. Neurology. 2002 Apr 23;58(8):1221-6.
  20. Hadjivassiliou M, Grunewald RA, Davies-Jones GA. Gluten sensitivity as a neurological illness.J Neurol Neurosurg Psychiatry. 2002 May;72(5):560-3. Review.
  21. Husby, V., Jensenius, C., Svehag, S.(1985). Passage of Undegraded DietaryAntigen into the Blood of Healthy Adults. Scandanavian Journal of Immunology. 22, 83-92.
  22. Ma A, Chen X, Zheng M, Wang Y, Xu R, Li J. Iron status and dietary intake of Chinese pregnant women with anaemia in the third trimester.Asia Pac J Clin Nutr. 2002;11(3):171-5.
  23. Kapil U, Bhavna A. Adverse effects of poor micronutrient status during childhood and adolescence.Nutr Rev. 2002 May;60(5 Pt 2):S84-90. Review.
  24. Youdim MB, Yehuda S. The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system.Cell Mol Biol (Noisy-le-grand). 2000 May;46(3):491-500.
  25. Otero GA, Aguirre DM, Porcayo R, Fernandez T. Psychological and electroencephalographic study in school children with iron deficiency.Int J Neurosci. 1999 Aug;99(1-4):113-21.
  26. Guesry P. The role of nutrition in brain development.
  27. Prev Med. 1998 Mar-Apr;27(2):189-94. Review.
  28. Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls.Lancet. 1996 Oct 12;348(9033):992-6.
  29. Soewondo S. The effect of iron deficiency and mental stimulation on Indonesian children's cognitive performance and development.Kobe J Med Sci. 1995 Apr;41(1-2):1-17.
  30. McCarthy AM, Lindgren S, Mengeling MA, Tsalikian E, Engvall JC. Effects of diabetes on learning in children.Pediatrics. 2002 Jan;109(1):E9.
  31. Bertini M, Sbarbati A, Valletta E, Pinelli L, Tato L. Incomplete gastric metaplasia in children with insulin-dependent diabetes mellitus and celiac disease. An ultrastructural study.BMC Clin Pathol. 2001;1(1):2.
  32. Schuppan D, Hahn EG. Celiac disease and its link to type 1 diabetes mellitus.J Pediatr Endocrinol Metab. 2001;14 Suppl 1:597-605.
  33. Holmes GK. Coeliac disease and Type 1 diabetes mellitus - the case for screening.Diabet Med. 2001 Mar;18(3):169-77. x
  34. Saukkonen T, Vaisanen S, Akerblom HK, Savilahti E. Coeliac disease in children and adolescents with type 1 diabetes: a study of growth, glycaemic control, and experiences of families.Acta Paediatr. 2002;91(3):297-302.
  35. Spiekerkoetter U, Seissler J, Wendel U. General Screening for Celiac Disease is Advisable in Children with Type 1 Diabetes.Horm Metab Res. 2002 Apr;34(4):192-5.
  36. Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F, Bianchi C, Chiumello G. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study.Pediatrics. 2002 May;109(5):833-8.
  37. Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Hegedu LS, Jacobsen BB, Husby S. High prevalence of coeliac disease in Danish children with type I diabetes mellitus.Acta Paediatr. 2001 Nov;90(11):1238-43.
  38. Aktay AN, Lee PC, Kumar V, Parton E, Wyatt DT, Werlin SL. The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin.J Pediatr Gastroenterol Nutr. 2001 Oct;33(4):462-5.
  39. MacFarlane AJ, Burghardt KM, Kelly J, Simell T, Simell O, Altosaar I, Scott FW. A type 1 diabetes-related protein from wheat (triticum aestivum): cDNA clone of a wheat storage globulin, Glb1, linked to islet damage.J Biol Chem. 2002 Oct 29.
  40. Scott FW, Rowsell P, Wang GS, Burghardt K, Kolb H, Flohe S. Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes.Diabetes. 2002 Jan;51(1):73-8.
  41. Scott FW, Cloutier HE, Kleemann R, Woerz-Pagenstert U, Rowsell P, Modler HW, Kolb H. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.Diabetes. 1997 Apr;46(4):589-98.
  42. Scott FW. Food-induced type 1 diabetes in the BB rat.Diabetes Metab Rev. 1996 Dec;12(4):341-59.
  • Of Relevant interest:
    Gormanous M, Hunt A, Pope J, Gerald B. Lack of knowledge of diabetes among Arkansas public elementary teachers: implications for dietitians. J Am Diet Assoc. 2002 Aug;102(8):1136-8.

Recovery: the Process of Healing
By Laura Yick

References:

  1. Grefte JM, et al. 1988. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 41: 886-91.
  2. Cummins AG, et al. 2001. Improvement in intestinal permeability precedes morphometric recovery of the small inestine in coeliac disease. Clin Sci (London) 100: 379-86.
  3. Wahab PJ. 2002. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 118: 459-63.
  4. Dickey W. 2000. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 95: 712-4.
  5. Fine KD, et al. 1997. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterol 112: 1830-8.
  6. Annibale B, et al. 2001. Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol 96: 132-37.
  7. Kemppainen T, et al. 2001. Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone 25: 355-60.
  8. Sategna-Guidetti C, et al. 2000. The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther 14: 35-43.